Trichome

GreenBroz Inc. Launches the Model G Precision Grinder + Destemmer, Transforming Cannabis Pre-Roll and Extraction Processing

Retrieved on: 
Tuesday, March 15, 2022
Trichome, Technology, Particle size, Allis-Chalmers Model G, Stainless steel, Pulverizer, THC, CEO, Engineering, R, Efficiency, Model

LAS VEGAS, March 15, 2022 /PRNewswire/ -- GreenBroz Inc., known as an industry-disruptive innovator of post-harvest processing technology for the cannabis industry, today officially announced the release of their Model G Precision Grinder + Destemmer .

Key Points: 
  • LAS VEGAS, March 15, 2022 /PRNewswire/ -- GreenBroz Inc., known as an industry-disruptive innovator of post-harvest processing technology for the cannabis industry, today officially announced the release of their Model G Precision Grinder + Destemmer .
  • Featuring a first-of-its-kind continuous throughput system, the Model G is the first combination destemmer and grinder on the market.
  • Removing stems from milled flower efficiently while maintaining product quality and controlling particle size have been substantial obstacles for operators to overcome.
  • The Model G comes with 1/8-inch, 5/32-inch or 3/16-inch mill size interchangeable screens, giving customers control and flexibility.

GreenBroz Inc. Launches the Model G Precision Grinder + Destemmer, Transforming Cannabis Pre-Roll and Extraction Processing

Retrieved on: 
Tuesday, March 15, 2022
Trichome, Technology, Particle size, Allis-Chalmers Model G, Stainless steel, Pulverizer, THC, CEO, Engineering, R, Efficiency, Model

LAS VEGAS, March 15, 2022 /PRNewswire/ -- GreenBroz Inc., known as an industry-disruptive innovator of post-harvest processing technology for the cannabis industry, today officially announced the release of their Model G Precision Grinder + Destemmer .

Key Points: 
  • LAS VEGAS, March 15, 2022 /PRNewswire/ -- GreenBroz Inc., known as an industry-disruptive innovator of post-harvest processing technology for the cannabis industry, today officially announced the release of their Model G Precision Grinder + Destemmer .
  • Featuring a first-of-its-kind continuous throughput system, the Model G is the first combination destemmer and grinder on the market.
  • Removing stems from milled flower efficiently while maintaining product quality and controlling particle size have been substantial obstacles for operators to overcome.
  • The Model G comes with 1/8-inch, 5/32-inch or 3/16-inch mill size interchangeable screens, giving customers control and flexibility.

BioHarvest Sciences Inc. Trademarks Its Breakthrough Non-GMO Proven Platform Technology: "BIO-PLANT CELLicitation"

Retrieved on: 
Wednesday, February 16, 2022
Intellectual property, CTO, PGG, Fruit, Company, Biotechnology, Dietary supplement, Terpene, Plant, Biomass, Canadian Securities Exchange, Polyphenol, BHSC, Technology, Functional food, Protein, Pomegranate, USD, Antioxidant, Trichome, Rehovot, Flow Science, Inc., CSE, Growth, Fine chemical, Medicinal plants, Cannabis, Cannabinoid

New name to reflect the Biotech power of combining plant cell growth with elicitation of specific molecules to produce unique compounds of high human utility value

Key Points: 
  • "The Bio-Plant CELLicitation proven platform technology allows us to address multiple market verticals with multiple products under different categories," said CEO Ilan Sobel.
  • The production in the industrial scale proprietary Bioreactors is done in aseptic conditions guaranteeing the highest levels of cleanliness.
  • BioHarvest recently announced that it produced a significant amount of Cannabis biomass without growing the plant itself, using the Bio-Plant CELLicitation platform technology.
  • BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange.

IM Cannabis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Retrieved on: 
Tuesday, February 8, 2022
NASDAQ, MACOM Technology Solutions, Industry, Forward-looking statement, Growth, Canadian Securities Exchange, MYM, SEDAR, Public opinion, CSE, Social media, Awareness, Technology, Trichome, IPO, COVID-19, Company, Perception, Cannabis, City, Agreement, Good, IFRS, Patient, TJAC, ESG, Pharmacy, Disease, Quality control, USD, SPAC, Tax, Public relations, Movement, IFRS 10, Ecosystem, Brooks, MZ, Risk, Drug, Pharmaceutical industry

TORONTO, ON and GLIL YAM, Israel, Feb. 8, 2022 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) ("IM Cannabis" or the "Company"), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has engaged international investor relations specialists MZ Group ("MZ") to lead the Company's strategic investor relations and financial communications program across all key markets.

Key Points: 
  • TORONTO, ON and GLIL YAM, Israel, Feb. 8, 2022 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) ("IM Cannabis" or the "Company"), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has engaged international investor relations specialists MZ Group ("MZ") to lead the Company's strategic investor relations and financial communications program across all key markets.
  • IM Cannabis (NASDAQ: IMCC) (CSE: IMCC) is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers.
  • In Germany, the IM Cannabis ecosystem operates through Adjupharm GmbH ("Adjupharm"), where it also distributes cannabis to pharmacies to medical cannabis patients.
  • MZ North America is the US division of MZ Group, a global investor relations and corporate communications leader.

IM Cannabis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Retrieved on: 
Tuesday, February 8, 2022
NASDAQ, MACOM Technology Solutions, Industry, Forward-looking statement, Growth, Canadian Securities Exchange, MYM, SEDAR, Public opinion, CSE, Social media, Awareness, Technology, Trichome, IPO, COVID-19, Company, Perception, Cannabis, City, Agreement, Good, IFRS, Patient, TJAC, ESG, Pharmacy, Disease, Quality control, USD, SPAC, Tax, Public relations, Movement, IFRS 10, Ecosystem, Brooks, MZ, Risk, Drug, Pharmaceutical industry

TORONTO, ON and GLIL YAM, Israel, Feb. 8, 2022 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) ("IM Cannabis" or the "Company"), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has engaged international investor relations specialists MZ Group ("MZ") to lead the Company's strategic investor relations and financial communications program across all key markets.

Key Points: 
  • TORONTO, ON and GLIL YAM, Israel, Feb. 8, 2022 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) ("IM Cannabis" or the "Company"), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has engaged international investor relations specialists MZ Group ("MZ") to lead the Company's strategic investor relations and financial communications program across all key markets.
  • IM Cannabis (NASDAQ: IMCC) (CSE: IMCC) is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers.
  • In Germany, the IM Cannabis ecosystem operates through Adjupharm GmbH ("Adjupharm"), where it also distributes cannabis to pharmacies to medical cannabis patients.
  • MZ North America is the US division of MZ Group, a global investor relations and corporate communications leader.

BioHarvest Sciences Inc. Plans to Build a Production Facility in Ontario to Serve the Canadian Market with Unique Cannabis Products

Retrieved on: 
Thursday, January 20, 2022
Plant, Technology, News, Science Inc., CBD, Biotechnology, CEO, BHSC, Cannabinoid, Canadian Securities Exchange, PST, THC, Biomass, Company, Rehovot, Agriculture, Trichome, CSE, Fruit, Drug, Cannabis

The Company is now producing Cannabis in industrial scale bioreactors and has entered the final stage of its Cannabis commercialization program

Key Points: 
  • This full spectrum, pesticide free, non-genetically modified biomass is based on the Company's proprietary BioFarming technology that produces Cannabis without growing the plant itself.
  • The Trichome cells contain Cannabinoids such as CBD, THC, as well as other compounds that grow naturally in the Cannabis plant.
  • I am excited about the opportunity to bring such unique Cannabis solutions to the Canadian market by building a local production facility in Canada.
  • Please register here: https://app.livestorm.co/st-financial/introduction-to-bioharvest?type=de...
    BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange.

BioHarvest Sciences Inc. 2021 CEO Letter to Shareholder Partners

Retrieved on: 
Thursday, December 30, 2021
Rehovot, LDL, Board, World IPv6 Day and World IPv6 Launch Day, Cannabinoid, Boldt, Biomass, News, CEO, OTC, Certification, The Globe and Mail, CAD, R & D, Technology, Industry, Fulfillment, Science, ATCS, Flavonoid, Marketing, The, Cardiology, Research, Trichome, CSE, VP, Motion, Growth, Ministry, Bioreactor, Female, Workforce, Partnership, ESG, New Year, US Market Access Center, GMP, NRF2, Director, Calendar, Advisory board, Terpene, Cannabis, Science Inc., Biophysical environment, Leadership, BHSC, List of health departments and ministries, Globe, ISO, Workplace, Acceleration, Pharmaceutical industry, Management, Drug, Fine chemical, Lithium, Public relations, Health

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 30, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) ("BioHarvest" or the "Company") is pleased to provide the following year-end shareholder partner letter from CEO Ilan Sobel.

Key Points: 
  • Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 30, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) ("BioHarvest" or the "Company") is pleased to provide the following year-end shareholder partner letter from CEO Ilan Sobel.
  • It is with great pleasure that I take this opportunity at the end of the year to summarize for our shareholder partners the major accomplishments of what has been an inspiring and transformative first full calendar year for me as CEO of BioHarvest Sciences.
  • While this highlight is only one of many from 2021, it represented a giant leap forward for BioHarvest Sciences.
  • Given the 2021 achievements record and the 2022 prospects listed below, we believe that BioHarvest presents a very attractive investment opportunity.

ABSTRAX Partners with Trichome Institute to Release First-Ever Cannabis Aromatic Training Kit

Retrieved on: 
Tuesday, December 14, 2021
Education, Menthol, CEO, Perception, Food, Health, Technology, Cosmetics, Cannabis, Entrepreneurship, Trigeminal nerve, Research, Beer, Gas chromatography, CBD, Terpene, Consultant, Industry, Medicinal plants, Drug, Perfume, Petroleum jelly, Management, Trichome

TUSTIN, Calif., Dec. 14, 2021 /PRNewswire-PRWeb/ --ABSTRAX, an industry leader in the study and production of cannabis and botanically derived terpenes, has partnered with the Trichome Institute to develop and distribute the very first cannabis aromatic training kit for interpening, opening the door for a new generation of cannabis sommeliers.

Key Points: 
  • TUSTIN, Calif., Dec. 14, 2021 /PRNewswire-PRWeb/ --ABSTRAX, an industry leader in the study and production of cannabis and botanically derived terpenes, has partnered with the Trichome Institute to develop and distribute the very first cannabis aromatic training kit for interpening, opening the door for a new generation of cannabis sommeliers.
  • "We are thrilled to partner with the Trichome Institute, as the industry and consumers will greatly benefit from this groundbreaking aroma kit," said Max Koby, Co-Founder and CEO of ABSTRAX.
  • Utilizing ABSTRAX'S terpenes and the Trichome Institute's interpening methodology, the Interpening Aromatic Training Kit has been designed to walk cannabis sommeliers through the most complex aspect of interpening the process of aroma scent perception to gauge the different effects.
  • The Interpening Aromatic Training Kit includes:
    Three (3) solid (crystalline) terpenes: Camphene, fenchyl alcohol, and menthol.

Leafly Announces 2021 Cannabis Strain of the Year

Retrieved on: 
Wednesday, December 8, 2021
Alternative Medicine, Online Retail, Retail, Health, Other Retail, Tobacco, Specialty, Sleep, Anxiety, Advertising, CA, Timeline of cannabis laws in the United States, Cannabis, GSC, Spotify, Industry, Trichome, Limonene, Moonbow, Dosi, Multimedia, Hall of Flame Fire Museum, Google Play, Pedigree, Seed, Year, Animal, Online shopping, Coffee

Leafly Holdings, Inc. (Leafly), one of the worlds leading cannabis discovery marketplaces and resources, today announced Dosidos as the 2021 Leafly Strain of the Year .

Key Points: 
  • Leafly Holdings, Inc. (Leafly), one of the worlds leading cannabis discovery marketplaces and resources, today announced Dosidos as the 2021 Leafly Strain of the Year .
  • The Leafly Strain of the Year is an annual honor bestowed upon a cannabis strain that demonstrated breakthrough market impact among the more than 5,000 strains in the Leafly strain database.
  • Dosidos emerged as the 2021 Leafly Strain of the Year thanks to the notable trajectory of this strain, which has risen in search traffic 10% year over year to crack Leaflys Top 20 most viewed strains nationwide for the first time in 2021.
  • When you see a Leafly Strain of the Year, you're meeting a fresh inductee into the cannabis Hall of Flame.

BioHarvest Sciences Inc. Produces Significant Amount of Cannabis Without Growing the Cannabis Plant

Retrieved on: 
Wednesday, December 8, 2021
Hemp, Human, CBD, Company, Population, Plant, Fungus, Biotechnology, CSE, Polyphenol, Technology, History, Trichome, Flow Science, Inc., Pain, Agriculture, Fruit, Safety, Social structure, F&B, Radiation, THC, Cannabinoid, Food, Industry, CS, Hazardous waste, Biomass, B2B, Canadian Securities Exchange, Time, CAD, BHSC, Drug, Seaweed, Food preservation

The Cannabis biomass is not genetically modified and was produced using the Company's proprietary BioFarming technology platform, which grows plant cells in their natural structure in proprietary bioreactors.

Key Points: 
  • The Cannabis biomass is not genetically modified and was produced using the Company's proprietary BioFarming technology platform, which grows plant cells in their natural structure in proprietary bioreactors.
  • "With this milestone, we are ready to start engaging with key players in the global Cannabis industry for the right partnerships ahead of the introduction of our new Cannabis products."
  • The biomass consists of Cannabis cells, including Cannabis Trichome cells containing Cannabinoids such as CBD, THC, as well as other compounds that are naturally occurring in the Cannabis plant.
  • Cost: A significant reduction in the production costs, resources, and time required versus indoor and greenhouse Cannabis cultivation.